Connect with us

Business

Why Marquie Group Inc (OTCMKTS:TMGI) May Surprise as a Speculative Star in the Making

Published

on

The CBD space has been stirring with an energy of rebounding sentiment so far in 2020, and one stock that may be positioned to benefit in dramatic fashion is Marquie Group Inc (OTCMKTS:TMGI).

What we like here is the fact that this one has more going in its favor than just the simple fact of involvement in the CBD theme. There are just too many CBD plays and we have developed a “tragedy of the commons” crowded theme narrative at this point. It may be bottoming in that fashion already, but it has already been a brutal ride for most of these stocks.

TMGI is different

This is a company targeting the health and beauty marketplace. And the x-factor here is Jacquie Carter Angell, who has been something of an all-star in the health and beauty market for two decades. She has established an internationally recognized personal brand as a beauty expert, appearing in television, radio, magazine, newspaper and media events around the world, and partnering with celebrities, Olympic athletes, doctors, nutritionists and a Nobel Prize laureate in brand-building and marketing health and beauty products to women in more than 90 countries.

Her specific power has been product development with a focus on the female consumer in the 35-49 age bracket. This specialty pushed her all the way to international director at Herbalife Nutrition, where she drove product development with great success before leaving to take the captain’s seat at The Marquie Group.

Now, in this new role, and with the world watching, the company just announced the upcoming release of a line of CBD tinctures in the weeks ahead, built from the ground up with a focus on differentiation through consumer experience.

There are two major problems for CBD companies right now: no plan for differentiation and no sense of target marketing. TMGI is entering this explosive space with unique and very plausible answers to both of those questions.

“The CBD market presents an excellent revenue opportunity for us because of the rapid growth rate defining the industry over the past two years. We’re a company that knows how to design products for women in the 35 to 49 age group, which is the largest demographic in the CBD marketplace,” stated Jacquie Carter Angell, president of The Marquie Group.

Hand Meet Glove

Marquie Group Inc (OTCMKTS:TMGI) bills itself as company directly targeting the CBD market for women in the 35-49 years range. The big edge here is its president, as noted.

And it just so happens that the women 35-49 demo is the most prolific in the rapidly growing CBD marketplace.

TMGI is a direct-to-consumer health and beauty products platform with a pipeline of innovative solutions to pervasive wellness concerns: anxiety, anti-aging, low energy, sleeplessness, and stress that use advanced formulations of plant-based, amino-acids and CBD alternatives to chemical ingredients.

All products will feature unique formulations of top-quality ingredients meant to impart skin health that comes from improved amino-acid balance and CBD nutrition.

Products planned for a 2020 launch include facial skin care serums, a powerful amino acid infused collagen drink and custom blended CBD tinctures each with their own potent puree of nature’s finest fruits, flowers and herbs. Each one is uniquely developed to provide optimal sleep and relaxation, mental focus and clarity or beauty and antioxidant benefits via an array of plant- based ingredients formulated to enhance one’s Inner Health and Outer Beauty.

Now commanding a market cap of $1.2M, TMGI is cheap and already pulling in trailing revenues. The company’s current push suggests top-line growth is overwhelmingly likely over the near and intermediate-term as it approaches the primary launch of its health and beauty platform in coming weeks.

As more color becomes clear on the name, we will review the situation and update our take.

Business

American Green Inc (OTCMKTS:ERBB) Achieves Breakeven In 2020, The First After Entering Cannabis Sector

Published

on

American Green Inc (OTCMKTS:ERBB) has reported operational breakeven in 2020. It is the first after entering the cannabis space. David Gwyther, president of American Green, said the company is putting in significant efforts to achieve self-sufficiency for several years while availing the funds from outside to meet the requirements. With this breakeven, the company needs to borrow less for operational needs and improve the bottom line.

Begins the sale of One HD Seltzer Water

American Green commenced the sale of One HD Seltzer Water through its one CBD store. The company expects to add additional retail stores in California, Nevada, and Arizona. Vice President (Sales – Worldwide) of American Green, Kevin Davis, said the company spent almost year in search of a 12 oz Can of CBD Seltzer/ Sparkling Water that comprises 25 mg of pharmaceutical grade CBD and zero THC for sale through its AGM Smart Vending Machines. The company also plans to sell CBD Seltzer/ Sparkling Water via its online stores to the customers directly.

Maintains highest standards for all CBD products

American Green shall always strive to maintain the highest standard for all the CBD products. The company will maintain a crisp and clean taste and consistency of pharmaceutical grade CBD in every CBD can. Davis said One HD Water meets all the requirements. It has even exceeded expectations.

One HD’s founder – Mike Falcione said he is thrilled that American Green has One HD Sparkling Seltzer Water for the distribution. He further said the company is aware that American Green is becoming one of the reputed brands in the nation to offer high-quality CBD products. One HD will extend all the necessary support to American Green to achieve the sales targets. Davis said the company is in discussions with Mike for the distribution of One HD CBD Seltzer Water. He looks forward to working with Mike and his team.

CBD as a viable solution to manage pain

The demand for CBD is very high because Americans consider it as a viable solution to manage and relieve pain. According to Nielsen, the leading data measurement authority, the market for CBD will reach $2.75 billion this year.

Continue Reading

Business

Why ISWH May Be a Prime Turnaround Opportunity in the Making

Published

on

For those in search of speculative turnaround potential in the small and micro-cap market space, you could do a whole lot worse than International Spirits & Wellness Holdings, Inc. (OTCMKTS:ISWH). The big picture here is a diversified branding play with commercial-stage operations already in place in the CBD, Wellness, Home Healthcare, and Spirits industries, and development stage operations in the Renewable Energy and Supply Chain & Logistics markets.

Based on recent financial performance, the company may have recently gotten past the point where its operational cash flows can start to fully support its future growth investments. For any micro-cap, this is the golden point in the investment cycle: when growth becomes non-dilutive. ISWH is either at or very near this point, posting EBITDA profitability and triple-digit topline growth in Q3 and Q4 of 2019.

ISWH recently completed a shareholder-friendly restructuring and reverse stock split to better align its price-per-share quote with common standards for investor perception.

Pro-tip: In our experience, when a company has this much going for it, and then does this type of restructuring and realignment, it’s typically in front of a lot of major positive news. The shift in structure and share price is to set the stage so that the company’s existing long-term shareholders can get the most bang for the buck on new strong announcements set to roll out over coming weeks and months.

In other words, the stage is set for some big happy news for ISWH. Take note.

In the words of the company’s President and Chairman, Alonzo Pierce: “A shareholder-friendly restructuring was necessary to strengthen our relationship with capital markets, pursue a near-term uplist to a higher exchange tier, and set in motion our operational strategy for 2020. We have a number of very compelling catalysts set to roll out, but we needed to provide a viable context – to lay a foundation for that success – as an initial step. We have achieved that with our restructuring and reverse split last week.”

That just about says it all.

The Foundation

The foundation for ISWH right now is its two main commercial-stage growth drivers: CBD-based products and the company’s rapidly growing home healthcare business.

The CBD products segment is positioned for rapidly accelerating growth this year following the signing of its defining partnership agreement with BioPulse Labs, a nationally-recognized brand development and manufacturing leader in the nano-infusion of CBD products. The BioPulse agreement provides for effectively a starter package in product development and marketing for the fresh launch of five new CBD-based wellness products. That will effectively push a restart button for the company’s P19 brand of CBD-based products.

The company also has an edge through this partnership due to the fact that it will be that rare CBD products brand able to boast that all of its products are formulated and produced in FDA compliant and registered facilities. This is becoming a huge issue in the current world of garage-band CBD producers. Consumers don’t know what they’re getting when they purchase CBD products. And they’re starting to figure that out.

The Home Healthcare segment is rapidly expanding as well. This division saw quadruple-digit percentage growth during the back half of 2019, and the company has implied that this trend is set to continue in Q1 2020.

Home healthcare spending is expected to reach more than $186 billion in 2027, according to a recent analysis from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary. This vastly surpasses any other category of health care service spending, even including hospital inpatient care, physician and professional services, nursing facilities, prescription drugs, retail sales of medical products and anything else you can think of.

ISWH has put in place a strong operational footprint in this rapidly expanding market, and we would look for continued strong performance throughout 2020.

Conclusion

With this foundation in place, a possible inflection toward non-dilutive growth in the quarters ahead, and now standing on the other side of the company’s recent shareholder-friendly restructuring, ISWH is an extremely interesting speculative opportunity, especially given our assumption that the company is getting ready to add some very strong new catalysts into the mix in coming weeks.

ISWH management drove this same sense home in its latest release: “This is truly all about embracing a very aggressive growth-oriented future path at ISWH,” continued Pierce. “We have put in place a winning framework as a genuine disruptor in the health and wellness space, and we continue to see dramatic growth in that endeavor, including strong financial performance over recent quarters. We are also entering several new markets, with a true edge already in place, and will be providing details on those strategic moves over the very near term. Long story short: we have some very exciting announcements ahead and we wanted to provide a solid structural foundation in the stock ahead of those catalysts for the benefit of our committed shareholders.”

Continue Reading

Business

ANVISA Authorizes Khiron Life Sciences Corp (OTCMKTS:KHRNF) To Import Medical Cannabis Products Into Brazil From Colombia

Published

on

Brazilian Health Regulatory Agency (ANVISA) has authorized Khiron Life Sciences Corp (OTCMKTS:KHRNF) to import medical cannabis products on an individual patient basis. Khiron can now apply for a license to export medical cannabis products to Brazil with this authorization. The company also needs the nod of TSX for the commercialization of cannabis in Brazil.

Khiron achieves a milestone

Director and Chief Executive Officer of Khiron, Alvaro Torres, said the company achieved another milestone on receiving the regulatory nod from ANVISA to introduce its medical cannabis products in the largest Latin American market. It allows the company to serve the patient population in that region. He further said Khiron work towards achieving authorizations in Peru and Colombia and improves its network in Brazil.

A regulatory framework to import medical cannabis

ANVISA has established a regulatory framework that involves a comprehensive procedure for the production and importing the medical cannabis products into Brazil. The medical cannabis products are prescribed by the physicians and marketed through pharmacies. Therefore, patients get safe access to legal medical cannabis products.  Cannabis is beneficial for regulating oily skin and helps to fight aging.

The market for medical cannabis

The demand for medical cannabis in Brazil expects to reach 1.4 billion in the next three years. Also, the patient base that comprises patients with chronic conditions in Brazil will increase to 3.4 million. The request for medical cannabis products in the nation almost tripled since 2015. Around 1,100 physicians are prescribing medical cannabis products to the patients.

Chairman of Khiron resigns

Sidney Himmel, chairman of Khiron, has resigned to pursue other interests. Following his resignation, Alvaro will act as interim chairman of the company. Deborah Rosati will head the audit committee.

Khiron formed a JV with Dixie Brands to focus on the development of cannabis products. As per the terms of the pact, Dixie will also engage in the manufacture and distribution of kuida brand CBD cosmeceuticals targeting Hispanic population in the US. The joint venture with Dixie Brands gives Khiron exposure to the US market.

Chris Naprawa is a president at Khiron. Before joining Khiron, he worked as MD at Primary Capital and as a partner at Sprott Capital Partners.

Continue Reading

FEATURED STORIES

Business1 hour ago

American Green Inc (OTCMKTS:ERBB) Achieves Breakeven In 2020, The First After Entering Cannabis Sector

Post Views: 45 American Green Inc (OTCMKTS:ERBB) has reported operational breakeven in 2020. It is the first after entering the...

Business7 hours ago

Why ISWH May Be a Prime Turnaround Opportunity in the Making

Post Views: 52 For those in search of speculative turnaround potential in the small and micro-cap market space, you could...

Business1 day ago

ANVISA Authorizes Khiron Life Sciences Corp (OTCMKTS:KHRNF) To Import Medical Cannabis Products Into Brazil From Colombia

Post Views: 224 Brazilian Health Regulatory Agency (ANVISA) has authorized Khiron Life Sciences Corp (OTCMKTS:KHRNF) to import medical cannabis products...

Business4 days ago

Cannabis Control Commission Grants License To Curaleaf Holdings Inc (OTCMKTS:CURLF) To Inaugurate Retail Dispensary In Massachusetts

Post Views: 226 Massachusetts Cannabis Control Commission has granted final license approval to Curaleaf Holdings Inc (OTCMKTS:CURLF) to inaugurate an...

Business5 days ago

Starseed Medicinal Inc, A Subsidiary Of WeedMD Inc (OTCMKTS:WDDMF), Becomes A Preferred Supplier Of Medical Cannabis To myHSA Program Participants In Canada

Post Views: 153 Starseed Medicinal Inc, a subsidiary of WeedMD Inc (OTCMKTS:WDDMF), has become a preferred supplier of medical cannabis...

Business6 days ago

Innovative Industrial Properties Inc (NYSE:IIPR) Acquires Toledo, Ohio processing facility And Leases Back To Green Thumb Industries Inc (OTCMKTS:GTBIF)

Post Views: 209 Innovative Industrial Properties Inc (NYSE:IIPR) has acquired Toledo, Ohio processing facility from Green Thumb Industries Inc (OTCMKTS:GTBIF)...

Whats Hot